Sequana Medical NV (STU:2SE) Total Equity: €-39.18 Mil (As of Jun. 2025)


STU:2SE Sequana Medical NV STU:2SE
34 GF Score
Price €0.51
GF Value €0.19
Valuation Significantly Overvalued
! 12 Warning Signs
View Full Analysis

What is Sequana Medical NV Total Equity?

Sequana Medical NV STU:2SE 34 Total Equity is €-39.18 Mil as of Jun. 2025. GuruFocus rates STU:2SE with a GF Score™ of 34/100 and a GF Value™ of €0.19 (Significantly Overvalued). The stock has 12 warning signs investors should review.

Sequana Medical NV's total equity for the quarter that ended in Jun. 2025 was €-39.18 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sequana Medical NV Total Equity Historical Data

* Premium members only.

The historical data trend for Sequana Medical NV's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequana Medical NV Total Equity Chart

Sequana Medical NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 -0.79 -2.15 -19.47 -44.38

Sequana Medical NV Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.61 -19.47 -19.56 -44.38 -39.18
STU:2SE
34GF Score
Sequana Medical NV STU:2SE
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sequana Medical NV Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sequana Medical NV's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=9.944-54.323
=-44.38

Sequana Medical NV's Total Equity for the quarter that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=14.571-53.746
=-39.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €-39.18 Mil mean?
Sequana Medical NV (STU:2SE) has a Total Equity of €-39.18 Mil as of Jun. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Sequana Medical NV and its competitors.
Is Sequana Medical NV's Total Equity too high?
Sequana Medical NV's current Total Equity is €-39.18 Mil. Overall, Sequana Medical NV has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's Total Equity compare to ABT and SYK?
Sequana Medical NV's Total Equity of €-39.18 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sequana Medical NV and its competitors. Sequana Medical NV's current Total Equity is €-39.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Sequana Medical NV (STU:2SE) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.19, compared to a current price of €0.51 — trading 168.9% above its estimated fair value. The current Total Equity is €-39.18 Mil. Sequana Medical NV's overall GF Score™ is 34/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sequana Medical NV (STU:2SE), the current Total Equity is €-39.18 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sequana Medical NV (STU:2SE) Overvalued in 2026?

Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued. The current stock price of €0.51 is trading 168.9% above its estimated GF Value™ of €0.19. GuruFocus considers Sequana Medical NV to be Significantly Overvalued.

Key valuation signals for STU:2SE:

  • Total Equity: €-39.18 Mil
  • GF Value™: €0.19 vs. price of €0.51 (168.9% above fair value)
  • GF Score™: 34/100 with 12 warning signs

No single metric tells the full story. See the STU:2SE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sequana Medical NV Business Description

Other Exchanges SEQUA:Belgium
Address Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
34GF Score

Get the complete analysis for STU:2SE

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price
€0.19
GF Value